REFERENCES
- Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008; 51: 714–725.
- Martens RJ, Henry RM, Houben AJ et al. Capillary rarefaction associates with albuminuria: the Maastricht study. J Am Soc Nephrol 2016; 27: 3748–3757.
- Cheng H, Harris RC. Renal endothelial dysfunction in diabetic nephropathy. Cardiovasc Hematol Disord Drug Targets 2014; 14: 22–33.
- Sati A, Jha A, Moulick PS et al. Corneal endothelial alterations in chronic renal failure. Cornea 2016; 35: 1320–1325.
- Rajendran P, Rengarajan T, Thangavel J et al. The vascular endothelium and human diseases. Int J Biol Sci 2013; 9: 1057–1069.
- Moriya T, Tanaka S, Kawasaki R et al. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan diabetes complications study. Diabetes Care 2013; 36: 2803–2809.
- Inoue K, Kato S, Inoue Y et al. The corneal endothelium and thickness in type II diabetes mellitus. Jpn J Ophthalmol 2002; 46: 65–69.
- Módis L Jr, Szalai E, Kertész K et al. Evaluation of the corneal endothelium in patients with diabetes mellitus type I and II. Histol Histopathol 2010; 25: 1531–1537.
- Bikbova G, Oshitari T, Tawada A et al. Corneal changes in diabetes mellitus. Curr Diabetes Rev 2012; 8: 294–302.
- Sudhir RR, Raman R, Sharma T. Changes in the corneal endothelial cell density and morphology in patients with type 2 diabetes mellitus: a population‐based study, Sankara Nethralaya diabetic retinopathy and molecular genetics study (SN‐DREAMS, report 23). Cornea 2012; 31: 1119–1122.
- Bourne WM. Biology of the corneal endothelium in health and disease. Eye (Lond) 2003; 17: 912–918.
- El‐agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus. Clin Ophthalmol 2017; 11: 481–486.
- Briggs S, Osuagwu UL, Alharthi EM. Manifestations of type 2 diabetes in corneal endothelial cell density, corneal thickness and intraocular pressure. J Biomed Res 2015; 30: 46–51.
- Storr‐paulsen A, Singh A, Jeppesen H et al. Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol 2014; 92: 158–160.
- Galgauskas S, Laurinavičiūtė G, Norvydaitė D et al. Changes in choroidal thickness and corneal parameters in diabetic eyes. Eur J Ophthalmol 2016; 26: 163–167.
- Hori J. Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation. J Ocul Biol Dis Infor 2008; 1: 94–100.
- Higuchi A, Ueno R, Shimmura S et al. Albumin rescues ocular epithelial cells from cell death in dry eye. Curr Eye Res 2007; 32: 83–88.
- Nees DW, Fariss RN, Piatigorsky J. Serum albumin in mammalian cornea: implications for clinical application. Invest Ophthalmol Vis Sci 2003; 44: 3339–3345.
- Riwanto M, Landmesser U. High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J Lipid Res 2013; 54: 3227–3243.
- Larsson LI, Bourne WM, Pach JM et al. Structure and function of the corneal endothelium in diabetes mellitus type I and type II. Arch Ophthalmol 1996; 114: 9–14.
- Chang CH, Chuang LM. Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: from risk association to risk prediction. J Diabetes Investig 2013; 4: 42–44.
- Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care 2014; 37: 867–875.